IBL HealthCare Limited has announced its financial results for the year ended June 30, 2026, revealing a modest growth in revenue and net profit compared to the previous year.
- Reporting Period: Year ended June 30, 2026 (audited)
- Revenue: PKR 4,607.11M (+6.6% YoY)
- Gross Profit: PKR 1,644.84M (+13.7% YoY)
- Net Profit (PAT): PKR 220.40M (+5.1% YoY)
- EPS: PKR 224 (previously PKR 208.37)
- Cash Dividend: Nil
- Bonus Shares: Nil
- Right Shares: Nil
- Main driver: Improved gross margins contributed to the revenue growth despite increased finance costs.